Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Baseline cross-sectional descriptive study from an ongoing trial, measuring associations between quality of life and symptom burden in treatment-naïve patients; provides foundational data but no intervention effect, control arm, or outcome data.
Single-centre, retrospective laboratory surveillance of bacterial isolates with descriptive epidemiology and resistance patterns; provides local data to guide therapy but lacks clinical outcomes, prospective enrolment, or comparison groups.
Single-centre retrospective laboratory surveillance study describing bacterial distribution and resistance patterns without intervention, comparator, or hypothesis testing; useful for local epidemiology but limited generalizability and no causal inference.
A narrative review synthesizing emerging preclinical and associative clinical evidence for a putative gut–prostate axis in BPH, acknowledging that current evidence remains largely mechanistic and associative with few direct human studies.
Single-centre cross-sectional surveillance study of bacterial isolates with descriptive and correlational findings; no interventional design, no clinical outcomes, and no comparison group to establish causation or clinical impact.
A single case report describing temporal association between SGLT2 inhibition, anatomic variants, and multidrug-resistant UTI; the authors explicitly state causality is unproven and the narrative is hypothesis-generating.
Large descriptive epidemiologic study using administrative data with no comparator or intervention; provides prevalence trends and demographic patterns but lacks analytical depth, causal inference, or clinical outcomes.
A policy brief presenting expert recommendations for managing infections in cancer patients amid antimicrobial resistance in sub-Saharan Africa, informed by institutional microbiological data but not a primary research study.